Study reveals rising young cancer cases due to accelerated aging, while UN predicts a 77% global increase by 2050; biotech sector responds with significant cancer treatment and diagnostics advancements.

A study shows rising cancer cases in young people due to "accelerated aging", while the UN predicts a 77% increase in global cancer cases by 2050. The biotech sector is responding with significant developments in cancer treatment and diagnostics, with the global cancer immunotherapy market expected to reach $314.4B by 2032. Companies like Oncolytics Biotech Inc., Celcuity Inc., Olema Pharmaceuticals, Bio-Rad Laboratories, and AstraZeneca PLC are leading these advancements.